Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity (Q90783045)
Jump to navigation
Jump to search
scientific article published on 28 June 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity |
scientific article published on 28 June 2018 |
Statements
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity (English)
David L Hermanson
Branden S Moriarity